Study: Unusual sensations, paranoia common in Parkinson’s patients
Approximately two-thirds of Parkinson’s disease patients may experience paranoia and unusual sensations, including visual hallucinations, according to a new…
Articles by Margarida Maia, PhD
LRRK2 regulator ID’d as potential therapeutic target in Parkinson’s
U.S. researchers have identified, as a potential therapeutic target in Parkinson’s disease, a protein that controls part of the…
C2N, MJFF team up to find link between Alzheimer’s, Parkinson’s
C2N Diagnostics and The Michael J. Fox Foundation for Parkinson’s Research (MJFF) are teaming up to study how…
Music beats improve walking in Parkinson’s rehabilitation: Study
A mobile application that detects a person’s natural walking pace and provides real-time, beat-synchronized music for at-home rehabilitation improved walking…
Cell therapy ANPD001 safe for first 2 trial Parkinson’s patient groups
Aspen Neuroscience has completed dosing the first two groups of patients in ASPIRO, an ongoing Phase 1/2a clinical trial…
Bemdaneprocel to move into Phase 3 trial soon
BlueRock Therapeutics said it is progressing its investigational cell therapy, bemdaneprocel, into a Phase 3 clinical trial set to…
Levodopa helps to ease muscle stiffness during faster movement
Levodopa, a standard Parkinson’s disease medication, may help alleviate muscle stiffness, one of the condition’s characteristic motor symptoms, by…
Mitochondrial dysfunction partly explained by immune responses
The number of copies of mitochondrial DNA in the blood of people with Parkinson’s disease are not a biomarker…
Study of Bial therapy for patients with GBA1 mutations advances
The first patient in a Phase 2 clinical study testing BIA 28-6156 — a small molecule in the pipeline at…
Biden honors Michael J. Fox with Presidential Medal of Freedom
Actor Michael J. Fox has received the Presidential Medal of Freedom from U.S. President Joe Biden for his work as…